Acasti Pharma Inc. Announces the Resignation of a Director

/PRNewswire/ -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ: ACST) a late-stage, specialty pharma company advancing three clinical stage drug...

Related Keywords

Canada ,United States ,Canadian ,Jean Marie John Canan ,Robert Blum ,Jan Dalvise ,Prnewswire Acasti Pharma Inc ,Nasdaq ,Board Of Directors The Company ,Acasti Pharma Inc ,Securities Exchange ,Lytham Partners ,Orphan Drug Designation ,Subarachnoid Hemorrhage ,Postherpetic Neuralgia ,Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,